{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:58:37Z","timestamp":1784689117123,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2274,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.seizure.2007.02.004","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T07:19:14Z","timestamp":1175066354000},"page":"345-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy"],"prefix":"10.1016","volume":"16","author":[{"given":"S.","family":"Grosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Cordelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Franzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Capovilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Verrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Morgese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Balestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2007.02.004_bib1","first-page":"426","article-title":"A new antiepileptic drug","volume":"72","author":"Shorvon","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2007.02.004_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/08830738050200020101","article-title":"Levetiracetam in pediatrics","volume":"20","author":"Vigevano","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2007.02.004_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","article-title":"Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices","volume":"306","author":"Niespodziany","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.seizure.2007.02.004_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.seizure.2007.02.004_bib5","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1528-1157.2001.41300.x","article-title":"Pharmacokinetic study of levetiracetam in children","volume":"42","author":"Pellock","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib7","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.0013-9580.2003.00403.x","article-title":"Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials","volume":"44","author":"Leppik","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib8","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2007.02.004_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Commission on classification and terminology of the International League Against Epilepsy, 1981","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on classification and terminology of the International League Against Epilepsy, 1989","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1528-1157.2001.10401.x","article-title":"A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology","volume":"42","author":"Engel","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0404.2006.00647.x","article-title":"Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial","volume":"113","author":"Genton","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2007.02.004_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2007.02.004_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1528-1157.2002.13101.x","article-title":"Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial","volume":"43","author":"Glauser","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.33588\/rn.3711.2003423","article-title":"Effectiveness and tolerability of levetiracetam in 43 children and adolescents with epilepsy","volume":"37","author":"Herranz","year":"2003","journal-title":"Rev Neurol"},{"key":"10.1016\/j.seizure.2007.02.004_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/088307380201700603","article-title":"Levetiracetam in refractory pediatric epilepsy","volume":"17","author":"Wheless","year":"2002","journal-title":"J Child Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2007.02.004_bib18","first-page":"S108","article-title":"Levetiracetam in the treatment of Lennox\u2013Gastaut syndrome","volume":"50","author":"De los Reyes","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2007.02.004_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.seizure.2005.08.002","article-title":"Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany","volume":"14","author":"Opp","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2007.02.004_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.seizure.2005.02.004","article-title":"Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy","volume":"14","author":"Grosso","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2007.02.004_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2004.10.004","article-title":"Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial","volume":"14","author":"Lagae","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2007.02.004_bib22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/08830738050200071001","article-title":"Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use","volume":"20","author":"Mandelbaum","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2007.02.004_bib23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/08830738040190120601","article-title":"Retrospective study of the use of levetiracetam in childhood seizure disorders","volume":"19","author":"Koukkari","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2007.02.004_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1090-3798(03)00041-2","article-title":"Effect of levetiracetam in refractory childhood epilepsy syndromes","volume":"7","author":"Lagae","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2007.02.004_bib25","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.56.12.1772","article-title":"Long-term continuation of levetiracetam in patients with refractory epilepsy","volume":"56","author":"Krakow","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2007.02.004_bib26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":"Levetiracetam psychosis in children with epilepsy","volume":"42","author":"Kossoff","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.02.004_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1059-1311(03)00111-0","article-title":"Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam","volume":"13","author":"Mula","year":"2004","journal-title":"Seizure"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131107000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131107000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:36:10Z","timestamp":1761010570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131107000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1059131107000441"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2007.02.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2007.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}